| Abstrakt: |
During more than 30 months of follow-up, an intravitreal fluocinolone acetonide implant that was noted to migrate freely between the vitreous cavity and anterior chamber resulted in no corneal edema or intraocular pressure rise. However, at 36-month follow-up, after second fluocinolone acetonide implant injection, mild corneal edema was noted, suggesting delayed damage induced by the migrating implants. Background/Purpose: To describe management of anterior migration of a fluocinolone acetonide(FAc) intravitreal implant. Methods: A retrospective case report. A 61-year-old man with diabetic macular edema and prior vitrectomy had anterior migration of a FAc implant. Anterior segment photos and optical coherence tomography were performed. Results: Approximately 3 months after FAc implant was administered, it was noted to have migrated into the anterior chamber. Vision, intraocular pressure, and optical coherence tomography imaging initially remained stable, and no evidence of detectable corneal edema developed in 30 months of follow-up. However, at 36 months of follow-up, after second FAc implant injection, mild corneal edema developed,suspected to be related to the migrating implants. Conclusion: Anterior migration of a FAc implant may lead to less rapid and severe corneal decompensation compared with other steroid implants. Despite this, delayed corneal edema may occur. Careful monitoring of the cornea and intraocular pressure is recommended in cases of anterior FAc migration. [ABSTRACT FROM AUTHOR] |
